lvv-hemorphin-7 has been researched along with scopolamine hydrobromide in 1 studies
| Studies (lvv-hemorphin-7) | Trials (lvv-hemorphin-7) | Recent Studies (post-2010) (lvv-hemorphin-7) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 59 | 0 | 14 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | lvv-hemorphin-7 (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albiston, AL; Burns, P; Chai, SY; Harding, JW; Mendelsohn, FA; Pederson, ES; Purcell, B; Weisinger, RS; Wright, JW | 1 |
1 other study(ies) available for lvv-hemorphin-7 and scopolamine hydrobromide
| Article | Year |
|---|---|
Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms.
Topics: Aminopeptidases; Analysis of Variance; Animals; Avoidance Learning; Cystinyl Aminopeptidase; Hemoglobins; Learning Disabilities; Male; Maze Learning; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Angiotensin; Scopolamine; Spatial Behavior | 2004 |